TY - JOUR
T1 - Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy
AU - Willemse, Peter-Paul M.
AU - Lam, Thomas
AU - Mottet, Nicolas
AU - Yuan, Cathy Yuhong
AU - Plass, Karin
AU - Donaldson, James
AU - Davis, Niall F.
AU - Dell'Oglio, Paolo
AU - Fankhauser, Christian
AU - Grivas, Nikos
AU - Ingels, Alexandre
AU - Lardas, Michael
AU - Liew, Matthew
AU - Pang, Karl H.
AU - Paterson, Catherine
AU - Omar, Muhammad Imran
AU - Zattoni, Fabio
N1 - Versions
05 January 2018
08 March 2018
04 August 2022
PY - 2022/8/4
Y1 - 2022/8/4
N2 - 1. To summarize the available data on deferred treatment with curative intent, including characteristics on populations, interventions, outcome measures and time points of outcome measurement. 2. To describe, explore and assess the heterogeneity of definitions, thresholds and criteria for patient eligibility, monitoring and reclassification.
AB - 1. To summarize the available data on deferred treatment with curative intent, including characteristics on populations, interventions, outcome measures and time points of outcome measurement. 2. To describe, explore and assess the heterogeneity of definitions, thresholds and criteria for patient eligibility, monitoring and reclassification.
M3 - Registered Reports
VL - 2018
JO - PROSPERO International prospective register of systematic reviews
JF - PROSPERO International prospective register of systematic reviews
M1 - CRD42018071780
ER -